Precision Medicine: Its Promises and Pitfalls Melissa S. Creary, PhD, MPH Health Management and Policy U-M School of Public Health

Size: px
Start display at page:

Download "Precision Medicine: Its Promises and Pitfalls Melissa S. Creary, PhD, MPH Health Management and Policy U-M School of Public Health"

Transcription

1 Precision Medicine: Its Promises and Pitfalls Melissa S. Creary, PhD, MPH Health Management and Policy U-M School of Public Health

2 Today s Outline 1. How did we get here? 2. Personalized vs. Precision 3. National Initiative 4. U-M Precision Health Initiative 5. Ethical Concerns and Other Problems 6. Resources 7. Question and Answer

3 How did we get here? Human Genome Project ( ) o identify all the approximately 20,000-25,000 genes in human DNA; providing the genetic blueprint for a human being o determine the sequences of the three billion chemical base pairs that make up human DNA; o store this information in databases; o improve tools for data analysis; o transfer related technologies to the private sector; and o address the ethical, legal and social issues that may arise from the project.

4 How did we get here? Human Genome Project ( ) o U.S. National Research Council Mapping and Sequencing the Human Genome (1988) o $3 Billion o Supported by U.S. Department of Energy, the U.S. National Institutes of Health (NIH), international and domestic collaborators and spurred by private competition o 15 years working draft produced in 2000

5 What the HGP gave us o Deeper understanding of medicine o Genomic architecture of genetic diseases (rare easier than common) o Better, more efficient, cheaper technologies o Ways to better think about data management and security o The next next frontiers: proteomics, pharmacogenomics, the microbiome, epigenome

6 What the HGP gave us o Shortcut that linked particular gene variants with specific diseases GWAS (genome-wide association studies) o Genomic Medicine Medical discipline that involves using genomic information about an individual as part of their clinical care

7 Personalized vs. Precision Personalized Medicine implies the prospect of devising a different treatment for each individual patient On one hand, that s how medicine is practiced every day, and on the other, it s a complete fallacy. - David Altshuler, geneticist, Broad Institute in Cambridge, Massachusetts

8 Personalized vs. Precision focuses on classifying individuals into subpopulations that differ in their susceptibility to a particular disease or in their response to a specific treatment an approach to integrating clinical and molecular information to understand the biological basis of disease enable more patient-centered clinical practice more research-oriented vs. more clinical practiceoriented.

9 Precision Medicine o GWAS studies are too limited o More data is necessary from many more people o Superimpose the entire genome and that data with: family history microbiome epigenome

10 National Initiatives: PMI o Announced at the 2015 State of the Union address o Lead by the White House with an all of government effort o Guiding Principles Creating a dynamic and inclusive governance structure Building trust and accountability through transparency Respecting participant preferences Empowering participants through access to information.

11 National Initiatives: All of Us o Name Change in October 2016 o Resides primarily within the NIH ($130 M) o Goal: 1 Million participants for the largest longitudinal study in the history of the United States All of Us represents the hope for all of us to come together to change the future of health care. The more people across America that participate, the more data they contribute to this research platform, and the more researchers who tap into the data, the greater our chances of unlocking medical breakthroughs.

12 Core Values Participation is open to all. Participants reflect the rich diversity of the U.S. Participants are partners. Participants have access to their information. Data will be accessed broadly for research purposes. Security and privacy will be of highest importance. The program will be a catalyst for positive change in research. Volunteers will contribute their health data and biospecimens to a centralized national database National launch Spring 2018 Democratizing Data Citizen Science

13 Why Now?

14 U-M Precision Health Initiative Language Matters: Precision Health vs. Precision Medicine Precision health at the University of Michigan expands far beyond medical treatment to include prevention, implementation, and community health. This initiative actively bridges these areas by promoting multidisciplinary collaboration among faculty across the university.

15 U-M Precision Health Initiative

16 U-M Precision Health Initiative

17 U-M Precision Health Initiative

18 U-M Precision Health Initiative

19 Ethical Concerns and Other Problems 1. Benefits will be unevenly distributed o Socioeconomic status o Geography o Race o Gender

20 Ethical Concerns and Other Problems 2. Participant Engagement o Not subjects Partners o Building trust o Continuous measurement :: continuous consent o Participant fatigue o Diversity

21 Ethical Concerns and Other Problems 3. Data Collection, Security and Privacy o Large amounts of data to be managed o Provision of individual level data o Social media integration o Centralized records

22 Ethical Concerns and Other Problems 4. Emphasis on Biological Difference/Citizenship o Lessons learned from HGP o Genetic profiling o New modes of discrimination o Immigration

23 Ethical Concerns and Other Problems 5. Bounded Justice (Creary, 2016) An attempt to distribute health rights without disturbing the underlying mechanisms that generated initial inequalities

24 Resources 1. All of Us: 2. U-M Precision Health: 3. Findings-SPH s Contribution to PH Reading List Available

25

Human Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987

Human Genomics, Precision Medicine, and Advancing Human Health. The Human Genome. The Origin of Genomics : 1987 Human Genomics, Precision Medicine, and Advancing Human Health Eric Green, M.D., Ph.D. Director, NHGRI The Human Genome Cells Nucleus Chromosome DNA Human Genome: 3 Billion Bases (letters) The Origin of

More information

Setting the stage: Privacy, security, regulation, and voluntary data sharing within Precision Medicine

Setting the stage: Privacy, security, regulation, and voluntary data sharing within Precision Medicine and Personalized Medicine Setting the stage: Privacy, security, regulation, and voluntary data sharing within UCSF Mini-Medical School November 7, 2013 Claire D. Brindis, Dr. P.H. Director, Philip R. Lee

More information

Genetics/Genomics in Public Health. Role of Clinical and Biochemical Geneticists in Public Health

Genetics/Genomics in Public Health. Role of Clinical and Biochemical Geneticists in Public Health Genetics/Genomics in Public Health Role of Clinical and Biochemical Geneticists in Public Health Premises Human variation is vast Strength of genetic factors are a continuum from low to high Testing technology

More information

Submission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008

Submission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008 (Previously Oxford NanoLabs) Genomic Medicine Submission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008 Introduction Oxford Nanopore Technologies

More information

Scientists don t yet fully

Scientists don t yet fully Alzheimer s Disease Genetics FACT SHEET Scientists don t yet fully understand what causes Alzheimer s disease. However, the more they learn about this devastating disease, the more they realize that genes*

More information

Personalized Human Genome Sequencing

Personalized Human Genome Sequencing Personalized Human Genome Sequencing Dr. Stefan Platz DABT, Global Head Drug Safety & Metabolism Biomedical research: strengths & limitations of non-animal alternatives 06 December 2016 The Human Genome

More information

Up Close and Personal

Up Close and Personal Special Report Up Close and With Personal advances in genetics, a new type of medicine has emerged: one that s tailored just for you and your DNA. Could it transform the paradigm of how we treat and prevent

More information

Introduction to Genomic Medicine Using Galaxy Platform (Workshop)

Introduction to Genomic Medicine Using Galaxy Platform (Workshop) Introduction to Genomic Medicine Using Galaxy Platform (Workshop) INTRODUCTION : Genomics is "an emerging medical discipline that involves using genomic information about an individual as part of their

More information

US Food and Drug Administration. Sandra L. Kweder, MD Deputy Director, Europe Office

US Food and Drug Administration. Sandra L. Kweder, MD Deputy Director, Europe Office US Food and Drug Administration Sandra L. Kweder, MD Deputy Director, Europe Office Basics Disclaimer The views in this presentation are my own I have no commercial involvement in any of these activities

More information

Comments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants

Comments on Use of Databases for Establishing the Clinical Relevance of Human Genetic Variants Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 The American Society of Human Genetics 9650 Rockville Pike Bethesda, MD 20814 24 December

More information

IDENTIFIABILITY OF THE HUMAN MICROBIOME: INVESTIGATOR PERSPECTIVES

IDENTIFIABILITY OF THE HUMAN MICROBIOME: INVESTIGATOR PERSPECTIVES IDENTIFIABILITY OF THE HUMAN MICROBIOME: INVESTIGATOR PERSPECTIVES Data Sharing Policies in Genomic Research Developed in the context of large-scale sequencing studies (HGP, HapMap) Primary purpose: create

More information

Information Technology for Genetic and Genomic Based Personalized Medicine. Submitted. April 23, 2008

Information Technology for Genetic and Genomic Based Personalized Medicine. Submitted. April 23, 2008 Information Technology for Genetic and Genomic Based Personalized Medicine Submitted April 23, 2008 By The Harvard Medical School Partners HealthCare Center for Genetics and Genomics in Partnership with

More information

THE CAMPAIGN FOR UC SANTA CRUZ THE GENOMICS INSTITUTE

THE CAMPAIGN FOR UC SANTA CRUZ THE GENOMICS INSTITUTE THE CAMPAIGN FOR UC SANTA CRUZ THE GENOMICS INSTITUTE The promise of genomics to revolutionize medicine and to transform our understanding of life itself is one of the great opportunities of our time.

More information

Frumkin, 2e Part 1: Methods and Paradigms. Chapter 6: Genetics and Environmental Health

Frumkin, 2e Part 1: Methods and Paradigms. Chapter 6: Genetics and Environmental Health Frumkin, 2e Part 1: Methods and Paradigms Chapter 6: Genetics and Environmental Health Genetics Genetics, the study of individual genes, has expanded to include genomics, which is the study of all the

More information

US Policy Developments and Points to Consider for Genomics Research Informed Consent

US Policy Developments and Points to Consider for Genomics Research Informed Consent US Policy Developments and Points to Consider for Genomics Research Informed Consent Marianna J. Bledsoe Independent Research Professional/Consultant Adjunct Assistant Professor George Washington University

More information

Improving Population Health One Person at a Time

Improving Population Health One Person at a Time Improving Population Health One Person at a Time Session #PH5, March 5, 2018 India Hook-Barnard, PhD Director, Research Strategy Associate Director, Precision Medicine 1 Conflict of Interest India Hook-Barnard,

More information

Biomedical Informatics in BIG DATA Era

Biomedical Informatics in BIG DATA Era Biomedical Informatics in BIG DATA Era Yang C. Fann, Ph.D. Director, Intramural IT and Bioinformatics Program National Institute of Neurological Disorders and Stroke Disclaimer The opinions or assertions

More information

Introduction to Bioinformatics

Introduction to Bioinformatics Introduction to Bioinformatics Richard Corbett Canada s Michael Smith Genome Sciences Centre Vancouver, British Columbia June 28, 2017 Our mandate is to advance knowledge about cancer and other diseases

More information

Complex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine

Complex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine Complex Adaptive Systems Forum: Transformative CAS Initiatives in Biomedicine January 18, 2013 Anna D. Barker, Ph.D. Director, Transformative Healthcare Networks C-Director, Complex Adaptive Systems Initiative

More information

- OMICS IN PERSONALISED MEDICINE

- OMICS IN PERSONALISED MEDICINE SUMMARY REPORT - OMICS IN PERSONALISED MEDICINE Workshop to explore the role of -omics in the development of personalised medicine European Commission, DG Research - Brussels, 29-30 April 2010 Page 2 Summary

More information

2017 Amplyus, all rights reserved

2017 Amplyus, all rights reserved The Human Genome Project What it is: The initiative that sequenced the entire human genome The Human Genome Project (HGP) is widely recognized as a tremendous success of government initiative and international

More information

Machine learning applications in genomics: practical issues & challenges. Yuzhen Ye School of Informatics and Computing, Indiana University

Machine learning applications in genomics: practical issues & challenges. Yuzhen Ye School of Informatics and Computing, Indiana University Machine learning applications in genomics: practical issues & challenges Yuzhen Ye School of Informatics and Computing, Indiana University Reference Machine learning applications in genetics and genomics

More information

GENETIC TESTING A Resource from the American College of Preventive Medicine

GENETIC TESTING A Resource from the American College of Preventive Medicine GENETIC TESTING A Resource from the American College of Preventive Medicine A Time Tool for Clinicians ACPM's Time Tools provide an executive summary of the most up-to-date information on delivering preventive

More information

Challenges and Issues for Pharmacogenomics Data Review in the FDA s VGDS Program

Challenges and Issues for Pharmacogenomics Data Review in the FDA s VGDS Program Challenges and Issues for Pharmacogenomics Data Review in the FDA s VGDS Program Weida Tong, Ph.D Director, Center for Toxicoinformatics, NCTR/FDA Weida.tong@fda.hhs.gov 1 A Novel Data Submission Path

More information

Challenges of Personalized Health for Clinical Medicine. Peter J Meier-Abt Swiss Academy of Medical Sciences (SAMS) Berne, Switzerland

Challenges of Personalized Health for Clinical Medicine. Peter J Meier-Abt Swiss Academy of Medical Sciences (SAMS) Berne, Switzerland Challenges of Personalized Health for Clinical Medicine Peter J Meier-Abt Swiss Academy of Medical Sciences (SAMS) Berne, Switzerland Personalisierte Medizin Personalisierte Gesundheit Personalisierte

More information

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001

Pharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 Pharmacogenetics: A SNPshot of the Future Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 1 I. What is pharmacogenetics? It is the study of how genetic variation affects drug response

More information

PMHDC Principal Investigators:

PMHDC Principal Investigators: OVERVIEW Precision Medicine (PM) is an approach to disease detection, prevention, and treatment based on people s individual differences. The Precision Medicine and Health Disparities Collaborative (PMHDC,

More information

Genomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC

Genomic Research: Issues to Consider. IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC Genomic Research: Issues to Consider IRB Brown Bag August 28, 2014 Sharon Aufox, MS, LGC Outline Key genomic terms and concepts Issues in genomic research Consent models Types of findings Returning results

More information

Reporting Results and Incidental Findings to Research Participants

Reporting Results and Incidental Findings to Research Participants Reporting Results and Incidental Findings to Research Participants Jeffrey R Botkin, MD, MPH Professor of Pediatrics Chief, Division of Medical Ethics and Humanities Associate Vice President for Research

More information

PERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS

PERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS PERSONALISED MEDICINE FOR THE BENEFIT OF PATIENTS CLEAR DIAGNOSIS TARGETED TREATMENT STRENGTHENED RESEARCH SUMMARY NATIONAL STRATEGY FOR PERSONALISED MEDICINE 2017-2020 FOREWORD Personalised Medicine

More information

University of Athens - Medical School. pmedgr. The Greek Research Infrastructure for Personalized Medicine

University of Athens - Medical School. pmedgr. The Greek Research Infrastructure for Personalized Medicine University of Athens - Medical School pmedgr The Greek Research Infrastructure for Personalized Medicine - George Kollias - Professor of Experimental Physiology, Medical School, University of Athens President

More information

Genome Sequencing: Applications and Newborn Screening. June 2, 2014

Genome Sequencing: Applications and Newborn Screening. June 2, 2014 Genome Sequencing: Applications and Newborn Screening June 2, 2014 Suzanne Cordovado, PhD Molecular Quality Improvement Program Centers for Disease Control and Prevention National Center for Environmental

More information

BOARD PAPER - NHS ENGLAND. Purpose of Paper: To inform the Board of the development of an NHS England Personalised Medicine Strategy.

BOARD PAPER - NHS ENGLAND. Purpose of Paper: To inform the Board of the development of an NHS England Personalised Medicine Strategy. Paper: PB.24.09.15/05 Title: Personalised Medicine Strategy. From: Sir Bruce Keogh, National Medical Director. BOARD PAPER - NHS ENGLAND Purpose of Paper: To inform the Board of the development of an NHS

More information

ACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes

ACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes ACCELERATING GENOMIC ANALYSIS ON THE CLOUD Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia

More information

LARGE DATA AND BIOMEDICAL COMPUTATIONAL PIPELINES FOR COMPLEX DISEASES

LARGE DATA AND BIOMEDICAL COMPUTATIONAL PIPELINES FOR COMPLEX DISEASES 1 LARGE DATA AND BIOMEDICAL COMPUTATIONAL PIPELINES FOR COMPLEX DISEASES Ezekiel Adebiyi, PhD Professor and Head, Covenant University Bioinformatics Research and CU NIH H3AbioNet node Covenant University,

More information

Personalized. Health in Canada

Personalized. Health in Canada Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute

More information

GENOMICS HEALTH FUTURES MISSION

GENOMICS HEALTH FUTURES MISSION GENOMICS HEALTH FUTURES MISSION July/August 2018 MRFF disbursements Over $2 billion available over first six years (>2016-17) 2016-17- $65.9m = 8 programs 2017-18- $1,651.7m = 11 new programs + 4 extensions

More information

Eric Green NHGRI Director

Eric Green NHGRI Director Bringing Genomic Medicine into Focus Eric Green, M.D., Ph.D. Director, NHGRI The Relevance of Genomics Biomedical Researchers Healthcare Professionals Patients (and Friends & Relatives of Patients) Human

More information

Just the Facts: A Basic Introduction to the Science Underlying NCBI Resources

Just the Facts: A Basic Introduction to the Science Underlying NCBI Resources National Center for Biotechnology Information About NCBI NCBI at a Glance A Science Primer Human Genome Resources Model Organisms Guide Outreach and Education Databases and Tools News About NCBI Site Map

More information

An innovative approach to genetic testing for improved patient care

An innovative approach to genetic testing for improved patient care An innovative approach to genetic testing for improved patient care Blueprint Genetics Blueprint Genetics is changing diagnostics by providing fast, affordable and comprehensive genetic knowledge Who we

More information

IMI: Accelerated Drug Portal. Julia Brosnan on behalf of Innovative Medicines Initiative

IMI: Accelerated Drug Portal. Julia Brosnan on behalf of Innovative Medicines Initiative IMI: Accelerated Drug Portal Julia Brosnan on behalf of Innovative Medicines Initiative Accelerating Medicines Partnership Type 2 Diabetes (AMP T2D) AMP T2D is a pre-competitive partnership among government,

More information

PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14

PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14 PHYSICIAN RESOURCES MAPPED TO GENOMICS COMPETENCIES AND GAPS IDENTIFIED WITH CURRENT EDUCATIONAL RESOURCES AVAILABLE 06/04/14 Submitted resources from physician organization representatives were mapped

More information

All of Us Research Program

All of Us Research Program All of Us Research Program National Minority Quality Forum Stephanie Devaney, PhD Deputy Director, All of Us Research Program June 21, 2018 #joinallofus All of Us Mission and Objectives Nurture relationships

More information

NIH Update James M. Anderson, M.D., Ph.D. NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives National Institutes of

NIH Update James M. Anderson, M.D., Ph.D. NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives National Institutes of NIH Update James M. Anderson, M.D., Ph.D. NIH Deputy Director for Program Coordination, Planning, and Strategic Initiatives National Institutes of Health AIRI Meeting October 2, 2017 Topics Budget Update

More information

GENOMICS for DUMMIES

GENOMICS for DUMMIES ØGC seminar 31. oktober 2013 GENOMICS for DUMMIES Torben A. Kruse Klinisk Genetisk Afdeling, Odense Universitetshospital Klinisk Institut, Syddansk Universitet Human MicroArray Center, OUH / SDU Årsag:

More information

Definition of Human Subject (94% oppose, 3% support, 3% support with qualifiers)

Definition of Human Subject (94% oppose, 3% support, 3% support with qualifiers) Research Universities and Institutions; Medical Centers and Schools of Medicine; Academic Institutional Review Boards and University and Medical Center Staff Preliminary Findings from a Review of Responses

More information

Nordic Common Strengths and Future Potential in the Field of Personalised Medicine

Nordic Common Strengths and Future Potential in the Field of Personalised Medicine Nordic Common Strengths and Future Potential in the Field of Personalised Medicine NOS-M Workshop 23rd November 2016 Stockholm Waterfront Johan Nilsson Coordinator Medicine and Health Swedish Research

More information

Ethics of Precision Medicine in Low to Middle Income Countries

Ethics of Precision Medicine in Low to Middle Income Countries Ethics of Precision Medicine in Low to Middle Income Countries Sola Olopade, MD, MPH Professor of Medicine Director, International Programs Faculty, MacLean Center for Clinical Ethics University of Chicago

More information

The experience of Andalusia in ehealth and big data --- Big data in health - IMI s HARMONY project, European Parliament, Brussels, 19 June 2018

The experience of Andalusia in ehealth and big data --- Big data in health - IMI s HARMONY project, European Parliament, Brussels, 19 June 2018 The experience of Andalusia in ehealth and big data --- Big data in health - IMI s HARMONY project, European Parliament, Brussels, 19 June 2018 Joaquín Dopazo Área de Bioinformática, Fundación Progreso

More information

Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health

Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Health TechNet & Pharmacogenomics (PGx) February 16, 2018 Franziska Moeckel AVP, Personalized Health Your genes. Your roadmap. Overview Inova s Precision Medicine Journey MediMap

More information

PAREXEL GENOMIC MEDICINE SERVICES. Applying genomics to enhance your drug development journey

PAREXEL GENOMIC MEDICINE SERVICES. Applying genomics to enhance your drug development journey PAREXEL GENOMIC MEDICINE SERVICES Applying genomics to enhance your drug development journey YOUR JOURNEY. OUR MISSION. Genomic expertise to simplify the route to product approval and maximize patient

More information

THE ERA OF INDIVIDUAL GENOMES. Sandra Viz Lasheras Advanced Genetics ( )

THE ERA OF INDIVIDUAL GENOMES. Sandra Viz Lasheras Advanced Genetics ( ) THE ERA OF INDIVIDUAL GENOMES Sandra Viz Lasheras Advanced Genetics (2017-2018) CONTENTS 1. INTRODUCTION - The genomic era - Sequencing techniques 2. PROJECTS - 1000 genomes project - Individual genome

More information

Lesson Overview. Studying the Human Genome. Lesson Overview Studying the Human Genome

Lesson Overview. Studying the Human Genome. Lesson Overview Studying the Human Genome Lesson Overview 14.3 Studying the Human Genome THINK ABOUT IT Just a few decades ago, computers were gigantic machines found only in laboratories and universities. Today, many of us carry small, powerful

More information

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University

Vision, aims and strategies. Department of Immunology, Genetics and Pathology Uppsala University Vision, aims and strategies Department of Immunology, Genetics and Pathology Uppsala University April19,2011 SCOPEOFACTIVITIESATIGP Research at the Department focuses on translational medicine through

More information

Satellite Education Workshop (SW4): Epigenomics: Design, Implementation and Analysis for RNA-seq and Methyl-seq Experiments

Satellite Education Workshop (SW4): Epigenomics: Design, Implementation and Analysis for RNA-seq and Methyl-seq Experiments Satellite Education Workshop (SW4): Epigenomics: Design, Implementation and Analysis for RNA-seq and Methyl-seq Experiments Saturday March 17, 2012 Orlando, Florida Workshop Description: This full day

More information

HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies

HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date. Genome Wide Association Studies Genome Wide Association Studies HRPP Policy No. 714 Effective Date 09/01/10 Revisions Date 1.0 Purpose This policy describes how investigators at the University of South Florida (USF) and USF Affiliates

More information

BIOSPECIMENS AND DATA SHARING CONSIDERATIONS FOR NATIVE PEOPLES

BIOSPECIMENS AND DATA SHARING CONSIDERATIONS FOR NATIVE PEOPLES BIOSPECIMENS AND DATA SHARING CONSIDERATIONS FOR NATIVE PEOPLES Náníbaa A. Garrison, Ph.D. Center for Biomedical Ethics and Society Vanderbilt University NCAI Tribal Leader/Scholar Forum June 28, 2015

More information

Molecular Diagnostics

Molecular Diagnostics Molecular Diagnostics Part II: Regulations, Markets & Companies By Prof. K. K. Jain MD, FRACS, FFPM Jain PharmaBiotech Basel, Switzerland May 2018 A Jain PharmaBiotech Report A U T H O R ' S B I O G R

More information

Pharmacogenetics of Drug-Induced Side Effects

Pharmacogenetics of Drug-Induced Side Effects Pharmacogenetics of Drug-Induced Side Effects Hui - Ching Huang Department of Pharmacy, Yuli Hospital DOH Department of Pharmacology, Tzu Chi University April 20, 2013 Brief history of HGP 1953: DNA

More information

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England

The NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England The NHS approach to personalised medicine in respiratory disease Professor Sue Hill @CSOSue Chief Scientific Officer for England Jul 2017 Genomics is probably the biggest breakthrough in the last 50 years.

More information

Evaluation and Regulation of Biomarkers A Public Health Perspective

Evaluation and Regulation of Biomarkers A Public Health Perspective Evaluation and Regulation of Biomarkers A Public Health Perspective Dr Ron Zimmern MA, FRCP, FFPHM Executive Director, PHG Foundation OECD Workshop on Policy Issues for the Development and Use of Biomarkers

More information

Visit our Career Flowchart to get more information on some of these career paths.

Visit our Career Flowchart to get more information on some of these career paths. Visit our Career Flowchart to get more information on some of these career paths. Academic Research Faculty: This career path consists of university or college professors who conduct research. They select

More information

2018/2019 final draft National Genomic Test Directory FAQ

2018/2019 final draft National Genomic Test Directory FAQ 2018/2019 final draft National Genomic Test Directory FAQ August 2018 1 Contents 1 Introduction... 3 2 About the Test Directory... 3 3 Frequently asked questions... 4 3.1 Where has the Test Directory been

More information

A New Era of Clinical Diagnostics: How the Business Model is Changing.

A New Era of Clinical Diagnostics: How the Business Model is Changing. A New Era of Clinical Diagnostics: How the Business Model is Changing. Nancy J Kelley, President and CEO of Nancy J Kelley & Associates Remarks to BTIG Emerging Technologies in Healthcare Diagnostics September

More information

NETWORKING AND CUREACCELERATOR LIVE!

NETWORKING AND CUREACCELERATOR LIVE! RARE DRUG DEVELOPMENT SYMPOSIUM A PARTNERSHIP BETWEEN PENN MEDICINE ORPHAN DISEASE CENTER AND GLOBAL GENES PHILADELPHIA, PENNSYLVANIA NETWORKING AND CUREACCELERATOR LIVE! CureAccelerator Live! Rare Disease

More information

The H3Africa and H3ABioNet Infrastructure

The H3Africa and H3ABioNet Infrastructure 1 The H3Africa and H3ABioNet Infrastructure Dr. Judit Kumuthini Judit.kumuthini@cpgr.org.za 19-22 nd Oct 2016 Where am I from? 2 3 Outline Introduction to H3A Who are we? Where are we? Capacity and Infrastructure

More information

Implications for the Future Issues in Ethics. David Castle Department of Philosophy University of Guelph

Implications for the Future Issues in Ethics. David Castle Department of Philosophy University of Guelph Implications for the Future Issues in Ethics David Castle Department of Philosophy University of Guelph dcastle@uoguelph.ca Ouline 1. Bread and butter bioethical issues a) Goals of Nutrigenomics b) Delivery

More information

Studying the Human Genome. Lesson Overview. Lesson Overview Studying the Human Genome

Studying the Human Genome. Lesson Overview. Lesson Overview Studying the Human Genome Lesson Overview 14.3 Studying the Human Genome THINK ABOUT IT Just a few decades ago, computers were gigantic machines found only in laboratories and universities. Today, many of us carry small, powerful

More information

Transforming care for the future

Transforming care for the future Transforming care for the future Professor Sue Hill @CSOSue Chief Scientific Officer for England Date 2017 The National Health Service (NHS) in numbers Semi-integrated system providing care to 55 million

More information

Learning Objectives. Introduction

Learning Objectives. Introduction Tools for Teaching Genetics in Primary Care Charles J. Macri, MD Leon Moore, Ph.D. NEGEA Baltimore, Maryland 3 March 2001 Learning Objectives Why is genetics an important topic for discussion now? Identify

More information

Genomics and personalised medicine

Genomics and personalised medicine Genomics and personalised medicine Dr Tom Fowler, Deputy Chief Scientist & Director of Public Health WHO Symposium on the Future of Digital Health Systems in the European Region February 2019 About me

More information

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS William S. Dalton, PhD, MD CEO, M2Gen & Director, Personalized Medicine Institute, Moffitt Cancer Center JULY 15, 2013 MOFFITT CANCER CENTER

More information

Presidential Commission for the Study of Bioethical Issues 2 nd meeting September

Presidential Commission for the Study of Bioethical Issues 2 nd meeting September Presidential Commission for the Study of Bioethical Issues 2 nd meeting September 13 14 2010 David B. Weiner, Ph.D. Professor Department of Pathology and Laboratory Medicine University of Pennsylvania

More information

The 100,000 Genomes Project

The 100,000 Genomes Project The 100,000 Genomes Project Dr Tom Fowler, Deputy Chief Scientist Genomics England Jillian Hastings Ward, Chair, National 100K Participant Panel The Kings Fund, 6th October 2017 Our Mission 100,000 whole

More information

Transform Clinical Research Into Value-Based Personalized Care

Transform Clinical Research Into Value-Based Personalized Care SAP Brief PUBLIC SAP Medical Research Insights Transform Clinical Research Into Value-Based Personalized Care SAP Brief Seamlessly combine clinical research with clinical routine Cutting-edge clinical

More information

Computational Biology

Computational Biology 3.3.3.2 Computational Biology Today, the field of Computational Biology is a well-recognised and fast-emerging discipline in scientific research, with the potential of producing breakthroughs likely to

More information

Overview of Health Informatics. ITI BMI-Dept

Overview of Health Informatics. ITI BMI-Dept Overview of Health Informatics ITI BMI-Dept Fellowship Week 5 Overview of Health Informatics ITI, BMI-Dept Day 10 7/5/2010 2 Agenda 1-Bioinformatics Definitions 2-System Biology 3-Bioinformatics vs Computational

More information

Danika Bannasch DVM PhD. School of Veterinary Medicine University of California Davis

Danika Bannasch DVM PhD. School of Veterinary Medicine University of California Davis Genetics 101 Danika Bannasch DVM PhD Maxine Adler Endowed Chair in Genetics School of Veterinary Medicine University of California Davis Outline Basic genetics: The Rules Not so basic genetics: The exceptions

More information

Synthetic Viruses Targeting Cancer

Synthetic Viruses Targeting Cancer Synthetic Viruses Targeting Cancer Andrew Hessel September 7, 2007 SENS 3, Cambridge, UK Why is a new strategy necessary? Breast cancer remains a significant cause of illness and death The treatment options

More information

INTERDISCIPLINARY COLLABORATIONS MEDICAL RECORDS AND GENOMICS (EMERGE) NETWORK AND EHRS: THE ELECTRONIC. October 30, 2015

INTERDISCIPLINARY COLLABORATIONS MEDICAL RECORDS AND GENOMICS (EMERGE) NETWORK AND EHRS: THE ELECTRONIC. October 30, 2015 INTERDISCIPLINARY COLLABORATIONS AND EHRS: THE ELECTRONIC MEDICAL RECORDS AND GENOMICS (EMERGE) NETWORK October 30, 2015 Dana C. Crawford, PhD Associate Professor Epidemiology and Biostatistics Institute

More information

Fundamentals of Clinical Genomics

Fundamentals of Clinical Genomics Fundamentals of Clinical Genomics Wellcome Genome Campus Hinxton, Cambridge, UK 17-19 January 2018 Lectures and Workshops to be held in the Rosalind Franklin Pavilion Lunch and Dinner to be held in the

More information

impact on a trial design and labeling

impact on a trial design and labeling Genotyping-impact impact on a trial design and labeling Yoshiaki Uyama,, Ph.D. Office of New Drug III (PMDA) Benefit of Pharmacogenomics Improving benefit/risk ratio More safe, more effective Adjusting

More information

Investimento & Inovação na Saúde

Investimento & Inovação na Saúde Investimento & Inovação na Saúde O Valor da Inovação na Saúde: uma visão para o futuro M. Carmo-Fonseca O valor da Inovação na Saúde Definir prioridades Investir na excelência Preparar as novas gerações

More information

Indigenizing Genomics

Indigenizing Genomics Indigenizing Genomics Enhancing genomic research through an indigenous perspective!! National Congress of American Indians! Science and Sovereignty! June 29, 2016 Indigenous Genome Scientists Katrina G.

More information

The Human Genome Project

The Human Genome Project The Human Genome Project The Human Genome Project Began in 1990 The Mission of the HGP: The quest to understand the human genome and the role it plays in both health and disease. The true payoff from the

More information

Measuring Chemicals in People What Would You Say? A Boston Consensus Conference on Biomonitoring. December 11, 2006

Measuring Chemicals in People What Would You Say? A Boston Consensus Conference on Biomonitoring. December 11, 2006 Measuring Chemicals in People What Would You Say? A Boston Consensus Conference on Biomonitoring Consensus Statement December 11, 2006 Government by the people and for the people. We represent the general

More information

Frequently Asked Questions

Frequently Asked Questions Frequently Asked Questions Genetics Defined What does DNA stand for? DNA stands for deoxyribonucleic acid. This term describes the different chemical building blocks that make up the structure of DNA.

More information

Our website:

Our website: Biomedical Informatics Summer Internship Program (BMI SIP) The Department of Biomedical Informatics hosts an annual internship program each summer which provides high school, undergraduate, and graduate

More information

Proposed Recommendations of the European Society of Human Genetics

Proposed Recommendations of the European Society of Human Genetics Genetic Testing and Common Disorders Proposed Recommendations of the European Society of Human Genetics DRAFT version 18 May 2009, PLEASE DO NOT QUOTE Introductory considerations After the focus on monogenic

More information

Integrating Genomics in Family Medicine

Integrating Genomics in Family Medicine Lehigh Valley Health Network LVHN Scholarly Works Department of Family Medicine Integrating Genomics in Family Medicine Brian Stello MD Lehigh Valley Health Network, Brian.Stello@lvhn.org Follow this and

More information

Genomes contain all of the information needed for an organism to grow and survive.

Genomes contain all of the information needed for an organism to grow and survive. Section 3: Genomes contain all of the information needed for an organism to grow and survive. K What I Know W What I Want to Find Out L What I Learned Essential Questions What are the components of the

More information

Community Health Initiative

Community Health Initiative Community Health Initiative Andy Faucett, MS, LGC Geisinger Health System IOM Roundtable on Translating Genomic-Based Research for Health November 19, 2015 wafaucett@geisinger.edu geisinger.org/genomics

More information

Are Next-Generation HPC Systems Ready for Population-level Genomics Data Analytics?

Are Next-Generation HPC Systems Ready for Population-level Genomics Data Analytics? www.bsc.es Are Next-Generation HPC Systems Ready for Population-level Genomics Data Analytics? Calvin Bulla, Lluc Alvarez and Miquel Moretó AACBB Workshop, 24/02/2018 Genome Sequencing Explosion Faster-than-Moore

More information

Chairman Cole, Ranking Member DeLauro and distinguished members of the

Chairman Cole, Ranking Member DeLauro and distinguished members of the Fiscal Year 2019 House Appropriations Committee Subcommittee on Labor, Health and Human Services, Education and Related Agencies Appropriations Testimony Cynthia A. Bens, Senior Vice President, Public

More information

Short Course Instructors

Short Course Instructors Short Course Instructors Andrew Allen, Ph.D., Professor of Biostatistics and Bioinformatics and Director of the new Duke Center of Statistical Genetics and Genomics, Duke University, has expertise in statistical

More information

European Genome phenome Archive at the European Bioinformatics Institute. Helen Parkinson Head of Molecular Archives

European Genome phenome Archive at the European Bioinformatics Institute. Helen Parkinson Head of Molecular Archives European Genome phenome Archive at the European Bioinformatics Institute Helen Parkinson Head of Molecular Archives What is EMBL-EBI? International, non-profit research institute Part of the European Molecular

More information

October 6, Below we provide input from our community of health informatics experts regarding select portions of the Draft Guidance.

October 6, Below we provide input from our community of health informatics experts regarding select portions of the Draft Guidance. Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Submitted electronically via http://www.regulations.gov RE: Use of Public Human Genetic

More information

4 th ESPT SUMMER SCHOOL

4 th ESPT SUMMER SCHOOL 4 th ESPT SUMMER SCHOOL PRECISION MEDICINE AND PERSONALISED HEALTH September 24-27, 2018 Geneva, Switzerland Dear Colleagues and Friends, It is a great pleasure and honour to invite you to the 4th ESPT

More information

Your story is unique. Diet & Exercise. Environment. Your health. Lifestyle. Genetics A PICTURE OF YOUR HEALTH

Your story is unique. Diet & Exercise. Environment. Your health. Lifestyle. Genetics A PICTURE OF YOUR HEALTH What s your story? Your story is unique It s a complex intersection of where you ve come from, and where your everyday choices are taking you. Optimal health choices for you might be different from others.

More information

All research lines at the LMU have a strong methodological focus

All research lines at the LMU have a strong methodological focus Content: Genetic Epidemiology and Statistical Genetics in Complex Diseases... 2 Molecular Epidemiology of Complex Phenotypes... 2 Clinical Trials and Translational Medicine... 3 Clinical Epidemiology and

More information